1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow John Sampson: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme PEP-3 vaccine, sargramostim, Temozolomide - Malignant Neoplasms of Brain | Phase 2 | Completed | John Sampson | 40 | 2007-09-01 | 2017-02-01 |
Glioblastoma (1) · Gliosarcoma (1)
Temozolomide (1) · sargramostim (1)
United States (1)
PMID 18775433, PMID 20921459, PMID 21149254
P50NS020023 (1)